Search Orphan Drug Designations and Approvals
-
Generic Name: | N-{2-[N-((3S)(3-piperidyl))carbamoyl]-5-[2-(3-fluorophenyl)ethynyl](3-thienyl)}aminoamide |
---|---|
Date Designated: | 04/29/2019 |
Orphan Designation: | Treatment of acute myeloid leukemia |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Pharos iBio Co., Ltd. #1408, 38, Heungan-daero 427 beon-gil Gwanyang-dong, Sungji Starwith), Dongan-gu, Anyang-si Gyeonggi-do South Korea The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-